{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:35:08Z","timestamp":1780486508911,"version":"3.54.1"},"reference-count":30,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease worldwide and is characterized by progressive muscle atrophy. There are currently two approved treatments, but they only relieve symptoms briefly and do not cure the disease. The main hindrance to research is the complex cause of ALS, with its pathogenesis not yet fully elucidated. Retinoids (vitamin A derivatives) appear to be essential in neuronal cells and have been implicated in ALS pathogenesis. This study explores 4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydroquinoxalin-2-yl)ethylnyl]benzoic acid (Ellorarxine, or DC645 or NVG0645), a leading synthetic retinoic acid, discussing its pharmacological mechanisms, neuroprotective properties, and relevance to ALS. The potential therapeutic effect of Ellorarxine was analyzed in vitro using the WT and SOD1G93A NSC-34 cell model of ALS at an administered concentration of 0.3\u201330 nM. Histological, functional, and biochemical analyses were performed. Elorarxine significantly increased MAP2 expression and neurite length, increased AMPA receptor GluA2 expression and raised intracellular Ca2+ baseline, increased level of excitability, and reduced Ca2+ spike during depolarization in neurites. Ellorarxine also displayed both antioxidant and anti-inflammatory effects. Overall, these results suggest Ellorarxine shows relevance and promise as a novel therapeutic strategy for treatment of ALS.<\/jats:p>","DOI":"10.3390\/ijms25189764","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:16:51Z","timestamp":1725938211000},"page":"9764","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of a Synthetic Retinoid, Ellorarxine, in the NSC-34 Cell Model of Motor Neuron Disease"],"prefix":"10.3390","volume":"25","author":[{"given":"Olivia","family":"Escudier","sequence":"first","affiliation":[{"name":"Department of Biosciences, Wolfson Research Institute for Health and Wellbeing, Durham University, Durham DH1 3LE, UK"},{"name":"Department of Chemistry, Science Laboratories, Durham University, Durham DH1 3LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Wolfson Research Institute for Health and Wellbeing, Durham University, Durham DH1 3LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8937-8445","authenticated-orcid":false,"given":"Andrew","family":"Whiting","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Science Laboratories, Durham University, Durham DH1 3LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-0379","authenticated-orcid":false,"given":"Paul","family":"Chazot","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Wolfson Research Institute for Health and Wellbeing, Durham University, Durham DH1 3LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ncl.2015.07.006","article-title":"Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis","volume":"33","author":"Statland","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","article-title":"The Epidemiology of ALS: A Conspiracy of Genes, Environment and Time","volume":"9","author":"Hardiman","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1602\/neurorx.1.1.5","article-title":"Mechanisms of Neural Cell Death: Implications for Development of Neuroprotective Treatment Strategies","volume":"1","author":"Yakovlev","year":"2004","journal-title":"NeuroRx"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bmb\/ldw026","article-title":"Pathogenesis of Amyotrophic Lateral Sclerosis","volume":"119","author":"Morgan","year":"2016","journal-title":"Br. Med. Bull."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2015.11.058","article-title":"Retinoids and Motor Neuron Disease: Potential Role in Amyotrophic Lateral Sclerosis","volume":"360","author":"Riancho","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jamaneurol.2017.5129","article-title":"Association of Serum Retinol-Binding Protein 4 Concentration with Risk for and Prognosis of Amyotrophic Lateral Sclerosis","volume":"75","author":"Rosenbohm","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s12035-020-01973-8","article-title":"All-Trans Retinoic Acid Exerts Neuroprotective Effects in Amyotrophic Lateral Sclerosis-Like Tg (SOD1*G93A)1Gur Mice","volume":"57","author":"Zhu","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_8","first-page":"130","article-title":"Retinoid Signaling Alterations in Amyotrophic Lateral Sclerosis","volume":"1","author":"Kolarcik","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1039\/c2ob25989c","article-title":"Disila-Analogues of the Synthetic Retinoids EC23 and TTNN: Synthesis, Structure and Biological Evaluation","volume":"10","author":"Gluyas","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Dehmelt, L., and Halpain, S. (2005). The MAP2\/Tau Family of Microtubule-Associated Proteins. Genome Biol., 6.","DOI":"10.1186\/gb-2004-6-1-204"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.stemcr.2018.04.024","article-title":"Retinoic Acid Is Required for Neural Stem and Progenitor Cell Proliferation in the Adult Hippocampus","volume":"10","author":"Mishra","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neuint.2013.03.008","article-title":"Differentiated NSC-34 Motoneuron-like Cells as Experimental Model for Cholinergic Neurodegeneration","volume":"62","author":"Maier","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrn2212","article-title":"Retinoic Acid in the Development, Regeneration and Maintenance of the Nervous System","volume":"8","author":"Maden","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tortelli, R., Zecca, C., Piccininni, M., Benmahamed, S., Dell\u2019Abate, M.T., Barulli, M.R., Capozzo, R., Battista, P., and Logroscino, G. (2020). Plasma Inflammatory Cytokines Are Elevated in ALS. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.552295"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.ATV.0000214296.94849.1c","article-title":"Synthetic Retinoid Am80 Reduces Scavenger Receptor Expression and Atherosclerosis in Mice by Inhibiting IL-6","volume":"26","author":"Takeda","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/cyto.1999.0588","article-title":"Retinoic Acid Suppresses Interleukin 6 Production in Normal Human Osteoblasts","volume":"12","author":"Ahmed","year":"2000","journal-title":"Cytokine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2008.09.003","article-title":"Decreased Expression of CD200 and CD200 Receptor in Alzheimer\u2019s Disease: A Potential Mechanism Leading to Chronic Inflammation","volume":"215","author":"Walker","year":"2009","journal-title":"Exp. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.14336\/AD.2019.0615","article-title":"Disease Progression-Dependent Expression of CD200R1 and CX3CR1 in Mouse Models of Parkinson\u2019s Disease","volume":"11","author":"Wang","year":"2020","journal-title":"Aging Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/glia.23811","article-title":"CD200 Maintains the Region-Specific Phenotype of Microglia in the Midbrain and Its Role in Parkinson\u2019s Disease","volume":"68","author":"Wang","year":"2020","journal-title":"Glia"},{"key":"ref_20","first-page":"4","article-title":"The Microglial-Motoneuron Dialogue in ALS","volume":"30","author":"Appel","year":"2011","journal-title":"Acta Myologica"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","article-title":"Oxidative Stress in ALS: A Mechanism of Neurodegeneration and a Therapeutic Target","volume":"1762","author":"Barber","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0891-5849(01)00495-6","article-title":"Retinoic Acid Reduces Apoptosis and Oxidative Stress by Preservation of SOD Protein Level","volume":"30","author":"Ahlemeyer","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/19396368.2022.2120439","article-title":"Retinoic Acid (All-Trans) Presents Antioxidant Properties within Human Ovary and Reduces Progesterone Production by Human Granulosa Cells","volume":"69","author":"Fonseca","year":"2023","journal-title":"Syst. Biol. Reprod. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1077-9108(08)70404-3","article-title":"GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis","volume":"2007","author":"Plowey","year":"2007","journal-title":"Yearb. Pathol. Lab. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.conb.2011.01.001","article-title":"GluA2-Lacking, Calcium-Permeable AMPA Receptors\u2014Inducers of Plasticity?","volume":"21","author":"Man","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_26","first-page":"624","article-title":"The Role of Ca2+ Permeable AMPA Receptors in Neurodegeneration, Neurotoxicity, and Neuroinflammation","volume":"22","year":"2022","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1748-1716.2006.01566.x","article-title":"Calcium Ions and Integration in Neural Circuits","volume":"187","author":"Verkhratsky","year":"2006","journal-title":"Acta Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/iub.91","article-title":"Calcium Ions in Neuronal Degeneration","volume":"60","author":"Wojda","year":"2008","journal-title":"IUBMB Life"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tins.2005.07.001","article-title":"Ca2+, Mitochondria and Selective Motoneuron Vulnerability: Implications for ALS","volume":"28","author":"Keller","year":"2005","journal-title":"Trends Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1152\/jn.00458.2014","article-title":"Retinoic Acid Affects Calcium Signaling in Adult Molluscan Neurons","volume":"113","author":"Vesprini","year":"2015","journal-title":"J. Neurophysiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/9764\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:52:36Z","timestamp":1760111556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/9764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":30,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijms25189764"],"URL":"https:\/\/doi.org\/10.3390\/ijms25189764","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]}}}